Logo

• Open gynecological cancer (KGOG3051)

  NRG-GY019: A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum

  • PI / PI기관 Kidong Kim /
  • Registration Date / Last Update Posted 2022-05-10 / 2022-05-11
  • Current Enrollment / Estimated Enrollment 150 person / 450 person (33.300000000000004%)

• Open gynecological cancer (KGOG3042)

  IDSHIPEC (Comparative effectiveness of HIPEC following interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy: Multicenter, prospective, cohort study)

  • PI / PI기관 Suk-Joon Chang /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-29
  • Current Enrollment / Estimated Enrollment 200 person / 204 person (98.0%)

• Under development gynecological cancer (KGOG4006)

  The analysis of 90-day postoperative mortality after debulking operation for primary advanced epithelial ovarian, tubal, peritoneal cancer

  • PI / PI기관 Yong Jung Song /
  • Registration Date / Last Update Posted 2023-03-14 / 2023-03-28
  • Current Enrollment / Estimated Enrollment person / 0 person (%)

• Under development gynecological cancer (KGOG4008)

  Study on the clinical utility of CIRCUlating tumor DNA methylation in the Screening of cervical and and ovarian cancers

  • PI / PI기관 Kidong Kim /
  • Registration Date / Last Update Posted 2023-03-14 / 2023-02-14
  • Current Enrollment / Estimated Enrollment person / 200 person (%)

• Under development gynecological cancer (KGOG4011)

  A prospective randomized controlled trial evaluating the safety and efficacy of patient blood management program in patients with gynecologic cancer

  • PI / PI기관 Jeong Yeol Park /
  • Registration Date / Last Update Posted 2023-03-14 / 2023-02-14
  • Current Enrollment / Estimated Enrollment person / 334 person (%)

• Under development gynecological cancer (KGOG3061)

  An open label, single arm, multi center, investigator initiated pilot study for the evaluation of the efficacy and safety of Immuncell-LC in patients with platinumresistant recurrent ovarian cancer

  • PI / PI기관 Sokbom Kang /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 48 person (0.0%)

• Under development gynecological cancer (KGOG3050)

  Laparoscopic/robotic vs Open Surgery in the Treatment of Apparently Early Stage Epithelial Ovarian Cancer

  • PI / PI기관 Jeong Yeol Park /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 461 person (0.0%)

• Under development gynecological cancer - (KGOG3033)

  Prospective study evaluating a strategy of surgery alone and surveillance in FIGO stage I malignant ovarian germ cell tumor

  • PI / PI기관 Jeong Yeol Park /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 0 person / 0 person (0.0%)

• Under development gynecological cancer (KGOG3031)

  • PI / PI기관 - /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 295 person / 264 person (111.7%)

• Under development gynecological cancer (KGOG3029)

  A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following First Line Platinum Based Chemotherapy

  • PI / PI기관 - /
  • Registration Date / Last Update Posted 2022-05-10 / 2023-03-28
  • Current Enrollment / Estimated Enrollment 87 person / 344 person (25.3%)

* (사)대한부인종양연구회는 게시된 세부 임상연구 정보에 대해 법적 책임이 없습니다.